These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 29678127)

  • 21. Cost-effectiveness of Bariatric Surgery: Increasing the Economic Viability of the Most Effective Treatment for Type II Diabetes Mellitus.
    Warren JA; Ewing JA; Hale AL; Blackhurst DW; Bour ES; Scott JD
    Am Surg; 2015 Aug; 81(8):807-11. PubMed ID: 26215244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2015 Jun; 53(6):19-22. PubMed ID: 26091546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes Mellitus in Greece.
    Tzanetakos C; Bargiota A; Kourlaba G; Gourzoulidis G; Maniadakis N
    Clin Drug Investig; 2018 Jan; 38(1):67-77. PubMed ID: 29080210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland.
    Lacey LA; Wolf A; O'shea D; Erny S; Ruof J
    Int J Obes (Lond); 2005 Aug; 29(8):975-82. PubMed ID: 15852050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of exenatide once-weekly versus dulaglutide, liraglutide, and lixisenatide for the treatment of type 2 diabetes mellitus: an analysis from the UK NHS perspective.
    Chuang LH; Verheggen BG; Charokopou M; Gibson D; Grandy S; Kartman B
    J Med Econ; 2016 Dec; 19(12):1127-1134. PubMed ID: 27310712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological Treatment for Obesity in Adults: An Umbrella Review.
    Khalil H; Ellwood L; Lord H; Fernandez R
    Ann Pharmacother; 2020 Jul; 54(7):691-705. PubMed ID: 31958967
    [No Abstract]   [Full Text] [Related]  

  • 27. A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.
    St Charles M; Minshall ME; Pandya BJ; Baran RW; Tunis SL
    Curr Med Res Opin; 2009 Jun; 25(6):1343-53. PubMed ID: 19419339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-Effectiveness of Total Knee Arthroplasty vs Nonoperative Management in Normal, Overweight, Obese, Severely Obese, Morbidly Obese, and Super-Obese Patients: A Markov Model.
    Ponnusamy KE; Vasarhelyi EM; Somerville L; McCalden RW; Marsh JD
    J Arthroplasty; 2018 Jul; 33(7S):S32-S38. PubMed ID: 29550168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of a low-calorie diet and orlistat for obese persons: modeling long-term health gains through prevention of obesity-related chronic diseases.
    van Baal PH; van den Berg M; Hoogenveen RT; Vijgen SM; Engelfriet PM
    Value Health; 2008 Dec; 11(7):1033-40. PubMed ID: 18494748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese: A Computer Model-Based Evaluation.
    McLawhorn AS; Southren D; Wang YC; Marx RG; Dodwell ER
    J Bone Joint Surg Am; 2016 Jan; 98(2):e6. PubMed ID: 26791039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-utility analysis of liraglutide versus glimepiride as add-on to metformin in type 2 diabetes patients in China.
    Gao L; Zhao FL; Li SC
    Int J Technol Assess Health Care; 2012 Oct; 28(4):436-44. PubMed ID: 23006540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease.
    Zomer E; Leach R; Trimmer C; Lobstein T; Morris S; James WP; Finer N
    Diabetes Obes Metab; 2017 Jan; 19(1):118-124. PubMed ID: 27649286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of add-on treatments to metformin in a Swedish setting: liraglutide vs sulphonylurea or sitagplitin.
    Steen Carlsson K; Persson U
    J Med Econ; 2014 Sep; 17(9):658-69. PubMed ID: 24950434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bariatric Surgery Coverage: a Comprehensive Budget Impact Analysis from a Payer Perspective.
    Palli SR; Rizzo JA; Heidrich N
    Obes Surg; 2018 Jun; 28(6):1711-1723. PubMed ID: 29468360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration.
    Konstantinidou SK; Argyrakopoulou G; Simati S; Stefanakis K; Kokkinos A; Analitis A; Mantzoros CS
    Diabetes Obes Metab; 2024 Aug; 26(8):3147-3154. PubMed ID: 38757729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of diet and exercise interventions to reduce overweight and obesity.
    Forster M; Veerman JL; Barendregt JJ; Vos T
    Int J Obes (Lond); 2011 Aug; 35(8):1071-8. PubMed ID: 21224825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United States.
    Wang B; Roth JA; Nguyen H; Felber E; Furnback W; Garrison LP
    PLoS One; 2015; 10(4):e0121915. PubMed ID: 25849542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of Bariatric Surgery in Adolescents With Obesity.
    Klebanoff MJ; Chhatwal J; Nudel JD; Corey KE; Kaplan LM; Hur C
    JAMA Surg; 2017 Feb; 152(2):136-141. PubMed ID: 27784062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic impact of hypoglycemia among insulin-treated patients with diabetes.
    Sussman M; Sierra JA; Garg S; Bode B; Friedman M; Gill M; Kaufman F; Vigersky R; Menzin J
    J Med Econ; 2016 Nov; 19(11):1099-1106. PubMed ID: 27292016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost-effectiveness of the LighterLife weight management programme as an intervention for obesity in England.
    Lewis L; Taylor M; Broom J; Johnston KL
    Clin Obes; 2014 Jun; 4(3):180-8. PubMed ID: 25826774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.